APLENZIN- bupropion hydrobromide tablet, extended release
Bausch Health US, LLC
----------
|
MEDICATION GUIDE APLENZIN® (uh-PLEN-zin) (bupropion hydrobromide) extended-release tablets |
|
|
IMPORTANT: Be sure to read the three sections of this Medication Guide. The first section is about the risk of suicidal thoughts and actions with antidepressant medicines; the second section is about the risk of changes in thinking and behavior, depression and suicidal thoughts or actions with medicines used to quit smoking; and the third section is entitled “What Other Important Information Should I Know About APLENZIN?” |
|
|
Antidepressant Medicines, Depression and Other Serious Mental Illnesses, and Suicidal Thoughts or Actions This section of the Medication Guide is only about the risk of suicidal thoughts and actions with antidepressant medicines. |
|
|
What is the most important information I should know about antidepressant medicines, depression and other serious mental illnesses, and suicidal thoughts or actions?
|
|
|
Call your healthcare provider right away if you or your family member has any of the following symptoms, especially if they are new, worse, or worry you:
|
|
|
What else do I need to know about antidepressant medicines?
It is not known if APLENZIN is safe and effective in children under the age of 18. |
|
|
Quitting Smoking, Quit-Smoking Medications, Changes in Thinking and Behavior, Depression, and Suicidal Thoughts or Actions This section of the Medication Guide is only about the risk of changes in thinking and behavior, depression and suicidal thoughts or actions with drugs used to quit smoking. Although APLENZIN is not a treatment for quitting smoking, it contains the same active ingredient (bupropion) as ZYBAN which is used to help patients quit smoking. Talk to your healthcare provider or your family member’s healthcare provider about:
When you try to quit smoking, with or without bupropion you may have symptoms that may be due to nicotine withdrawal, including: |
|
|
|
|
Some people have even experienced suicidal thoughts when trying to quit smoking without medication. Sometimes quitting smoking can lead to worsening of mental health problems that you already have, such as depression. Some people have had serious side effects while taking bupropion to help them quit smoking, including: New or worse mental health problems, such as changes in behavior or thinking, aggression, hostility, agitation, depression, or suicidal thoughts or actions. Some people had these symptoms when they began taking bupropion, and others developed them after several weeks of treatment, or after stopping bupropion. These symptoms happened more often in people who had a history of mental health problems before taking bupropion than in people without a history of mental health problems. Stop taking APLENZIN and call your healthcare provider right away if you, your family, or caregiver notice any of these symptoms. Work with your healthcare provider to decide whether you should continue to take APLENZIN. In many people, these symptoms went away after stopping APLENZIN, but in some people symptoms continued after stopping APLENZIN. It is important for you to follow up with your healthcare provider until your symptoms go away. Before taking APLENZIN, tell your healthcare provider if you have ever had depression or other mental health problems. You should also tell your healthcare provider about any symptoms you had during other times you tried to quit smoking, with or without bupropion. What Other Important Information Should I Know About APLENZIN?
The chance of having seizures increases with higher doses of APLENZIN. For more information, see the sections “Who should not take APLENZIN?” and “What should I tell my healthcare provider before taking APLENZIN?” Tell your healthcare provider about all of your medical conditions and all the medicines you take. Do not take any other medicines while you are taking APLENZIN unless your healthcare provider has said it is okay to take them. If you have a seizure while taking APLENZIN, stop taking the tablets and call your healthcare provider right away. Do not take APLENZIN again if you have a seizure.
If you have any of the above symptoms of mania, call your healthcare provider.
Only some people are at risk for these problems. You may want to undergo an eye examination to see if you are at risk and receive preventative treatment if you are. Severe allergic reactions. Some people can have severe allergic reactions to APLENZIN. Stop taking APLENZIN and call your healthcare provider right away if you get a rash, itching, hives, fever, swollen lymph glands, painful sores in the mouth or around the eyes, swelling of the lips or tongue, chest pain, or have trouble breathing. These could be signs of a serious allergic reaction. |
|
APLENZIN is a prescription medicine used to treat adults with a certain type of depression called major depressive disorder and for the prevention of autumn-winter seasonal depression (seasonal affective disorder). |
|
|
Who should not take APLENZIN? Do not take APLENZIN if you:
|
|
|
What should I tell my healthcare provider before taking APLENZIN? Tell your healthcare provider if you have ever had depression, suicidal thoughts or actions, or other mental health problems. You should also tell your healthcare provider about any symptoms you had during other times you tried to quit smoking, with or without APLENZIN. See “Quitting Smoking, Quit-Smoking Medications, Changes in Thinking and Behavior, Depression, and Suicidal Thoughts or Actions.”
Tell your healthcare provider about all the medicines you take, including prescription, over-the-counter medicines, vitamins, and herbal supplements. Many medicines increase your chances of having seizures or other serious side effects if you take them while you are taking APLENZIN. |
|
|
How should I take APLENZIN?
|
|
|
What should I avoid while taking APLENZIN?
|
|
|
What are possible side effects of APLENZIN? APLENZIN can cause serious side effects. See the sections at the beginning of this Medication Guide for information about serious side effects of APLENZIN.
|
|
|
|
|
If you have trouble sleeping, do not take APLENZIN too close to bedtime. Tell your healthcare provider right away about any side effects that bother you. These are not all the possible side effects of APLENZIN. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Bausch Health US, LLC at 1-800-321-4576. |
|
|
How should I store APLENZIN?
Keep APLENZIN and all medicines out of the reach of children. |
|
|
General information about the safe and effective use of APLENZIN. Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use APLENZIN for a condition for which it was not prescribed. Do not give APLENZIN to other people, even if they have the same symptoms you have. It may harm them. If you take a urine drug screening test, APLENZIN may make the test result positive for amphetamines. If you tell the person giving you the drug screening test that you are taking APLENZIN, they can do a more specific drug screening test that should not have this problem. This Medication Guide summarizes important information about APLENZIN. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about APLENZIN that is written for health professionals. For more information about APLENZIN, go to www.APLENZIN.com or call 1-800-321-4576. |
|
|
What are the ingredients in APLENZIN? Active ingredient: bupropion hydrobromide Inactive ingredients: ethylcellulose, glyceryl dibehenate, polyvinyl alcohol, polyethylene glycol, povidone, and dibutyl sebacate. Carnauba wax is included in the 174 mg and 348 mg strengths. The tablets are printed with edible black ink. |
|
|
Distributed by: Bausch Health US, LLC Bridgewater, NJ 08807 USA Manufactured by: Bausch Health Companies Inc. Steinbach, MB R5G 1Z7, Canada APLENZIN is a registered trademark of Bausch Health Companies Inc. or its affiliates. Wellbutrin XL is a registered trademark of GlaxoSmithKline LLC used under license. All other product/brand names and/or logos are the trademarks of their respective owners. U.S. Patent Numbers: 7,241,805; 7,569,610; 7,572,935; 7,585,897; 7,645,802; 7,649,019; 7,662,407 and 7,671,094 © 2025 Bausch Health Companies Inc. or its affiliates |
|
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Revised: 11/2025
|
9386812 20006032 |